295
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Vitamin D Receptor Polymorphism and the Response to Helicobacter Pylori Treatment

ORCID Icon, , , , , , ORCID Icon, , , , , & show all
Pages 4463-4469 | Received 21 Apr 2023, Accepted 10 Jun 2023, Published online: 08 Jul 2023

References

  • Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev. 2013;37(5):736–761. doi:10.1111/1574-6976.12027
  • Rana R, Wang SL, Li J, Wang YX, Rao QW, Yang CQ. Helicobacter pylori infection: a recent approach to diagnosis and management. Review. J Biomed Sci. 2017;2:45–56. doi:10.7150/jbm.17612
  • Abo-Amer YE, Sabal A, Ahmed R, et al. Relationship between helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) in a developing country: a cross-sectional study. Diabetes Metab Syndr Obes. 2020;13:619–625. doi:10.2147/dmso.S237866
  • Kusters JG, Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev. 2006;19(3):449–490. doi:10.1128/cmr.00054-05
  • Guo L, Chen W, Zhu H, et al. Helicobacter pylori induces increased expression of the vitamin d receptor in immune responses. Helicobacter. 2014;19(1):37–47. doi:10.1111/hel.12102
  • Yang L, He X, Li L, Lu C. Effect of vitamin D on Helicobacter pylori infection and eradication: a meta-analysis. Helicobacter. 2019;24(5):e12655. doi:10.1111/hel.12655
  • El Shahawy MS, Hemida MH, El Metwaly I, Shady ZM. The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection. JGH Open. 2018;2(6):270–275. doi:10.1002/jgh3.12081
  • Shafrir A, Shauly-Aharonov M, Katz LH, Paltiel O, Pickman Y, Ackerman Z. The association between serum vitamin D levels and helicobacter pylori presence and eradication. Nutrients. 2021;13(1):278. doi:10.3390/nu13010278
  • Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci USA. 1998;95(18):10529–10534. doi:10.1073/pnas.95.18.10529
  • Alagarasu K, Honap T, Mulay AP, Bachal RV, Shah PS, Cecilia D. Association of vitamin D receptor gene polymorphisms with clinical outcomes of dengue virus infection. Hum Immunol. 2012;73(11):1194–1199. doi:10.1016/j.humimm.2012.08.007
  • Sortica VA, Cunha MG, Ohnishi MD, et al. IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil. Malar J. 2012;11:409. doi:10.1186/1475-2875-11-409
  • Salimi S, Farajian-Mashhadi F, Alavi-Naini R, Talebian G, Narooie-Nejad M. Association between vitamin D receptor polymorphisms and haplotypes with pulmonary tuberculosis. Biomed Rep. 2015;3(2):189–194. doi:10.3892/br.2014.402
  • Colin EM, Weel AE, Uitterlinden AG, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol. 2000;52(2):211–216. doi:10.1046/j.1365-2265.2000.00909.x
  • Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–311. doi:10.1093/nar/29.1.308
  • Mohamed AA, Moussa S, Shaheen MM, et al. Association between vitamin d receptor gene polymorphisms and infection. Open Biomark J. 2020;10(1):8–14. doi:10.2174/1875318302010010008
  • Nogueira C, Figueiredo C, Carneiro F, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001;158(2):647–654. doi:10.1016/s0002-9440(10)64006-0
  • Gong M, Ling SS, Lui SY, Yeoh KG, Ho B. Helicobacter pylori gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology. 2010;139(2):564–573. doi:10.1053/j.gastro.2010.03.050
  • Kawaura A, Takeda E, Tanida N, et al. Inhibitory effect of long term 1α-hydroxyvitamin administration on helicobacter pylori infection. J Clin Biochem Nutr. 2006;38(2):103–106. doi:10.3164/jcbn.38.103
  • Youssef DA, Miller CW, El-Abbassi AM, et al. Antimicrobial implications of vitamin D. Dermatoendocrinol. 2011;3(4):220–229. doi:10.4161/derm.3.4.15027
  • Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflamm Res. 2014;63(10):803–819. doi:10.1007/s00011-014-0755-z
  • Yildirim O, Yildirim T, Seckin Y, Osanmaz P, Bilgic Y, Mete R. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med. 2017;26(9):1377–1381. doi:10.17219/acem/65430
  • White JH. Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord. 2012;13(1):21–29. doi:10.1007/s11154-011-9195-z
  • Qadir J, Majid S, Khan MS, Wani MD. Association of Vitamin D receptor gene variations with Gastric cancer risk in Kashmiri population. Mol Biol Rep. 2021;48(4):3313–3325. doi:10.1007/s11033-021-06376-z
  • Martins DJ, Matos GC, Loiola RS, D’Annibale V, Corvelo T. Relationship of vitamin D receptor gene polymorphisms in Helicobacter pylori gastric patients. Clin Exp Gastroenterol. 2018;11:19–27. doi:10.2147/ceg.S143332
  • Eom SY, Yim DH, Kim DH, et al. Dietary vitamin D intake and vitamin D related genetic polymorphisms are not associated with gastric cancer in a hospital-based case-control study in Korea. J Biomed Res. 2018;32(4):257–263. doi:10.7555/jbr.32.20170089
  • Huang B, Yan S, Chen C, Ye S. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes. Wien Klin Wochenschr. 2019;131(3–4):75–80. doi:10.1007/s00508-018-1416-y
  • Ramas M, Donday MG, McNicholl AG, Gisbert JP. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: a Phase IV pilot clinical trial. Gastroenterol Hepatol. 2017;40(10):658–662. doi:10.1016/j.gastrohep.2017.05.017
  • Ahmed HM, Abd-Elsalam S, Mahrous MA. Moxifloxacin based triple therapy as alternative to standard therapy in Helicobacter Pylori Eradication. Anti-Infective Agents. 2021;19(3):299–302. doi:10.2174/2211352518999200925154501
  • Abd-Elsalam S, Kobtan A, El-Kalla F, et al. A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: a single center experience. Medicine. 2016;95(24):e3879. doi:10.1097/md.0000000000003879
  • Shehata MA, Talaat R, Soliman S, Elmesseri H, Soliman S, Abd-Elsalam S. Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection. Helicobacter. 2017;22:5.
  • Fock KM, Chelvam P, Lim SG. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. Aliment Pharmacol Ther. 2000;14(2):225–231. doi:10.1046/j.1365-2036.2000.00691.x
  • Gebeyehu E, Nigatu D, Engidawork E. Helicobacter pylori eradication rate of standard triple therapy and factors affecting eradication rate at Bahir Dar city administration, Northwest Ethiopia: a prospective follow up study. PLoS One. 2019;14(6):e0217645. doi:10.1371/journal.pone.0217645
  • Xin Y, Manson J, Govan L, et al. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis. BMC Gastroenterol. 2016;16(1):80. doi:10.1186/s12876-016-0491-7